Octant Doses First Patient in Phase 1b/2 OCT-980 Study
EMERYVILLE, Calif. — September 24, 2026 Octant, Inc. announced that the first patient has been dosed in the Phase...
rare disease
Advertisement
ANI Gains FDA Approval for Everolimus Oral Suspension Tablets
PRINCETON, N.J. — September 23, 2026 ANI Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted...
Rhythm Gains Health Canada Approval for IMCIVREE in HO
BOSTON — September 22, 2026 Rhythm Pharmaceuticals announced that Health Canada has approved IMCIVREE® (setmelanotide) for weight management in...
Filana Gains FDA Lift of Simufilam Clinical Hold
AUSTIN, Texas — September 22, 2026 Filana Therapeutics announced that the U.S. Food and Drug Administration has lifted the...
Ionis Reports Positive Phase 3 Ulefnersen Results
Carlsbad, California, U.S., September 22, 2026 Ionis Pharmaceuticals, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. have announced positive...
Advertisements
Quoin Gains FDA Fast Track for QRX003 in Peeling Skin Syndrome
ASHBURN, Va. — September 22, 2026 Quoin Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Fast...
Arcturus to Present ARCT-810 Phase 2 OTC Deficiency Data
SAN DIEGO — September 18, 2026 Arcturus Therapeutics announced plans to provide an update on its ARCT-810 Phase 2...
Beacon Therapeutics Reports Positive VISTA Data for Laru-zova
LONDON and CAMBRIDGE, Mass September 21, 2026 — Beacon Therapeutics announced positive topline results from the pivotal VISTA trial...
Abeona Congratulates Ultragenyx on FAYUVI FDA Approval
CLEVELAND, Ohio — September 18, 2026 Abeona Therapeutics congratulated Ultragenyx Pharmaceutical on the U.S. FDA approval of FAYUVI™ (rebisufligene...
Zealand Pharma Gains Positive CHMP Opinion for Zeydovio
Zealand Pharma Gains Positive CHMP Opinion for Zeydovio Zealand Pharma announced that the Committee for Medicinal Products for Human...
Advertisement
